NCT00140348已完成1 期
A Phase I/II Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine in Patients With Metastatic Hormone-Refractory Prostate Cancer
Cell Genesys24 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2001年12月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 试验地点
- 24
研究概览
简要总结
The purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum tolerated dose.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of adenocarcinoma of the prostate
- •Metastatic prostate cancer deemed to be unresponsive or refractory to hormone therapy
- •Detectable metastases
- •ECOG performance status of 0 or 1
排除标准
- •Transitional cell, small cell, neuroendocrine, or squamous cell prostate cancer
- •Significant cancer related pain
- •Prior gene therapy, chemotherapy, or immunotherapy
研究者
研究点 (24)
Loading locations...
相似试验
已完成
1 期
An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid TumorsNeoplasms by SiteNCT01968109Bristol-Myers Squibb1,482
已完成
1 期
A Study of PLX2853 in Advanced Malignancies.Uveal MelanomaNon-Hodgkin LymphomaAdvanced MalignanciesSolid TumorDiffuse Large B Cell LymphomaSmall Cell Lung CancerFollicular LymphomaOvarian Clear Cell CarcinomaNCT03297424Opna Bio LLC49
招募中
1 期
Study of ZGGS18 in Patients With Advanced Solid TumorsAdvanced Solid TumorNCT05584800Suzhou Zelgen Biopharmaceuticals Co.,Ltd222
已完成
1 期
KX01 Ointment Phase 1 Study in Patients With Plaque Type PsoriasisPsoriasisNCT05522816PharmaEssentia28
招募中
1 期
Study of SRP-1001 in Adult and Adolescent Participants With Facioscapulohumeral Muscular Dystrophy Type 1Muscular Dystrophy, FacioscapulohumeralNCT06131983Sarepta Therapeutics, Inc.60